Posts Tagged School of Arts and Sciences

Daniel Weix, associate professor of chemistry, has been named a fellow of the American Association for the Advancement of Science (AAAS), the world’s largest general scientific society.

On Display, a “deconstructed art exhibit,” explores the diversity of the human form. The piece been performed around the world and had its Rochester premiere at the Memorial Art Gallery in October. A December performance is planned at the Disability Studies Cluster conference.

Challenging a long-held convention, University researchers have shown they can inhibit the influenza A virus by targeting its genomic RNA with “antisense” compounds.

The International Theatre Program closes its fall semester with guest director Pirronne Yousefzadeh’s production of what she calls “a love letter to the theater.”

Professor of Economics and Bloomberg View columnist Narayana Kocherlakota explains the role of polls—and statistical forecasting in general—as part of the U.S. election process.

A fall film series hosted by InVisible Culture, an electronic visual studies journal celebrating its 25th anniversary year at the University, and the George Eastman Museum, explores the power of looking.

In an effort spearheaded by Rochester faculty, more than 300 political scientists from across the United States have signed a statement voicing their collective concern about Republican presidential nominee Donald Trump.

As a freshman, Skylar Cerbone ’20 normally wouldn’t take Lynda Powell’s intermediate course, American Elections, this fall. But Cerbone didn’t want to wait. “It’s a presidential election year,” the political science major says. “I had to take this class now. It’s too important not to.”

The pending election has dominated news cycles for the past year. Four professors at the University of Rochester each raised and answered an important question they say we should be asking this election season.

University researchers hope to improve the odds of surviving acute myeloid leukemia by loading a promising compound into nanoparticles that will target the inner recesses of bone marrow where leukemia stem cells lurk.